Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2012
08/08/2012CN101803531B China cryptoporus sinensis and solid cultural method and application thereof
08/08/2012CN101792489B Preparation and application of human galectin-9 deletant for enhancement of immune response
08/08/2012CN101341981B Dietary cure beverage
08/08/2012CN101243053B N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
08/08/2012CN101190306B Compound composition with qi-complementing and spleen-invigorating function and preparation method and application thereof
08/07/2012US8236836 Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof
08/07/2012US8236562 Method for producing ready to use, antigen-loaded or unloaded, cryoconserved mature dendritic cells
08/07/2012US8236507 Modulators of TNF receptor associated factor (TRAF), their preparation and use
08/07/2012US8236487 Tumor specific oligosaccharide sequences and use thereof
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012US8236324 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
08/07/2012US8236321 Chemically programmable immunity
08/07/2012US8236143 Controlling chemical reactions by spectral chemistry and spectral conditioning
08/07/2012CA2514992C Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
08/07/2012CA2513544C An otorhinological delivery device
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/07/2012CA2461708C Delivery system for biological component
08/07/2012CA2457652C Soluble t cell receptor
08/07/2012CA2412782C Cyclic urea compounds and preparation thereof
08/07/2012CA2402213C Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
08/07/2012CA2368088C Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines
08/07/2012CA2309676C Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
08/07/2012CA2286344C Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
08/07/2012CA2146895C Ctla4/cd28ig hybrid fusion proteins
08/02/2012WO2012103365A1 Recombinant t cell ligands and antibodies that bind b cells for the treatment of autoimmune diseases
08/02/2012WO2012102937A2 Compounds that expand hematopoietic stem cells
08/02/2012WO2012101062A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
08/02/2012WO2012101032A1 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
08/02/2012WO2012101013A1 Substituted pyridinyl-pyrimidines and their use as medicaments
08/02/2012WO2012100732A1 Retinoid-related orphan receptor gamma modulators, composition containing them and uses thereof
08/02/2012WO2012100459A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
08/02/2012WO2012064300A3 Desloratadine granules
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120196934 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof
08/02/2012US20120196919 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
08/02/2012US20120196911 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
08/02/2012US20120196906 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors
08/02/2012US20120196902 Sulfoximines as kinase inhibitors
08/02/2012US20120196899 Methods and products for treating inflammation
08/02/2012US20120196884 Urea substituted sulphonamide derivatives
08/02/2012US20120196878 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
08/02/2012US20120196875 Pharmaceutical compositions for treatment of respiratory and inflammatory diseases
08/02/2012US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors
08/02/2012US20120196862 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196861 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196860 Triazine derivatives and their therapeutical applications
08/02/2012US20120196838 Compounds for inflammation and immune-related uses
08/02/2012US20120196829 Method of using beta-hydroxy-beta-methylbutyrate for the prevention and treatment of disease conditions
08/02/2012US20120196825 Compositions and methods for modulating the immune system
08/02/2012US20120196807 Kidney-targeting drug delivery agent comprising recombinant gelatin
08/02/2012US20120196805 Compositions and methods to control angiogenesis with cupredoxins
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195975 Immune stimulatory infant nutrition
08/02/2012US20120195972 Ophthalmic formulations and uses thereof
08/02/2012US20120195962 Multiepitope Vaccine for Her2/Neu-Associated Cancers
08/02/2012US20120195943 Bone delivery device
08/02/2012US20120195937 Polyanionic polymer adjuvants for haemophilus influenzae b saccharide vaccines
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195933 Pharmaceutical compositions comprising tasocitinib
08/02/2012US20120195932 Geodate delivery vehicles
08/02/2012US20120195930 Novel pyridine derivatives
08/02/2012US20120195929 Compounds that modulate autoimmunity and methods of using the same
08/02/2012US20120195928 Vaccines and methods for using the same
08/02/2012US20120195927 Gm-negative ehv-mutants without heterologous elements
08/02/2012US20120195926 Methods of improving vaccine immunogenicity
08/02/2012US20120195925 Vaccines with increased immunogenicity and methods for obtaining them
08/02/2012US20120195924 Adenoviral vector vaccine
08/02/2012US20120195922 Methods for preparing complex multivalent immunogenic conjugates
08/02/2012US20120195919 Hybrid and tandem expression of neisserial proteins
08/02/2012US20120195917 Vaccine Composition Comprising 5'-CAP Modified RNA
08/02/2012US20120195915 IAP BIR domain binding compounds
08/02/2012US20120195909 Antibodies against a proliferating inducing ligand (april)
08/02/2012US20120195904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
08/02/2012US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid
08/02/2012US20120195900 Tri-variable domain binding proteins and uses thereof
08/02/2012US20120195899 Immunizing Compositions and Methods of Use
08/02/2012US20120195898 Immunizing Compositions and Methods of Use
08/02/2012US20120195892 Immunoglobulin molecules with improved characteristics
08/02/2012US20120195888 Humanized Antibodies Against Human Interferon-Alpha
08/02/2012US20120195884 Methods and products for evaluating an immune response to a therapeutic protein
08/02/2012US20120195882 lipoparticle comprising a protein and methods of making and using the same
08/02/2012US20120195868 Nutritional compositions comprising fiber and probiotics
08/02/2012US20120195867 Probiotic containing modules for tube feeding
08/02/2012US20120195854 Granulysin in immunotherapy
08/02/2012US20120195852 Vaccines, immunotherapeutics and methods for using the same
08/02/2012US20120195832 Process for producing an injectable medicament preparation
08/02/2012CA2825858A1 Phosphorus-containing group-substituted quinoline, its preparation process, medical composition containing the compound and application
08/01/2012EP2481757A1 Treatment of multiple sclerosis and/or rheumatoid arthritis
08/01/2012EP2481748A2 Foxp3 peptide vaccine
08/01/2012EP2481739A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
08/01/2012EP2481425A1 Toll like receptor 3 antagonists, methods and uses
08/01/2012EP2481419A2 Neisserial vaccines
08/01/2012EP2480557A2 Process for the preparation of rapamycin derivatives
08/01/2012EP2480554A1 Macrocyclic inhibitors of jak
08/01/2012EP2480549A1 Fused imidazo [3, 2 - d]pyrazines as pi3 kinase inhibitors
08/01/2012EP2480242A1 Lipopolysaccharide isolated from pyrularia tissue and/or pyrularia-associated bacteria and uses thereof
08/01/2012EP2167124B1 The use of monomycolyl glycerol (mmg) as an adjuvant
08/01/2012EP2163554B1 Pyrimidodiazepinone derivative
08/01/2012EP1940465B1 Novel use of anti il-1beta antibodies
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 1172